BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

516 related articles for article (PubMed ID: 27835739)

  • 1. Examining the association between attention deficit hyperactivity disorder and substance use disorders: A familial risk analysis.
    Yule AM; Martelon M; Faraone SV; Carrellas N; Wilens TE; Biederman J
    J Psychiatr Res; 2017 Feb; 85():49-55. PubMed ID: 27835739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does exposure to parental substance use disorders increase offspring risk for a substance use disorder? A longitudinal follow-up study into young adulthood.
    Yule AM; Wilens TE; Martelon M; Rosenthal L; Biederman J
    Drug Alcohol Depend; 2018 May; 186():154-158. PubMed ID: 29573650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Familial risk analyses of attention deficit hyperactivity disorder and substance use disorders.
    Biederman J; Petty CR; Wilens TE; Fraire MG; Purcell CA; Mick E; Monuteaux MC; Faraone SV
    Am J Psychiatry; 2008 Jan; 165(1):107-15. PubMed ID: 18006872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attention-deficit/hyperactivity disorder and risk for substance use disorders in relatives.
    Skoglund C; Chen Q; Franck J; Lichtenstein P; Larsson H
    Biol Psychiatry; 2015 May; 77(10):880-6. PubMed ID: 25457227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Massachusetts General Hospital studies of gender influences on attention-deficit/hyperactivity disorder in youth and relatives.
    Biederman J; Faraone SV
    Psychiatr Clin North Am; 2004 Jun; 27(2):225-32. PubMed ID: 15063995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substance use disorders in adolescents with attention deficit hyperactivity disorder: a 4-year follow-up study.
    Groenman AP; Oosterlaan J; Rommelse N; Franke B; Roeyers H; Oades RD; Sergeant JA; Buitelaar JK; Faraone SV
    Addiction; 2013 Aug; 108(8):1503-11. PubMed ID: 23506232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine and serotonin genetic risk scores predicting substance and nicotine use in attention deficit/hyperactivity disorder.
    Groenman AP; Greven CU; van Donkelaar MM; Schellekens A; van Hulzen KJ; Rommelse N; Hartman CA; Hoekstra PJ; Luman M; Franke B; Faraone SV; Oosterlaan J; Buitelaar JK
    Addict Biol; 2016 Jul; 21(4):915-23. PubMed ID: 25752199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of prior stimulant treatment for attention-deficit/hyperactivity disorder on subsequent risk for cigarette smoking and alcohol and drug use disorders in adolescents.
    Wilens TE; Adamson J; Monuteaux MC; Faraone SV; Schillinger M; Westerberg D; Biederman J
    Arch Pediatr Adolesc Med; 2008 Oct; 162(10):916-21. PubMed ID: 18838643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial risk analysis of the association between attention-deficit/hyperactivity disorder and psychoactive substance use disorders.
    Milberger S; Faraone SV; Biederman J; Chu MP; Wilens T
    Arch Pediatr Adolesc Med; 1998 Oct; 152(10):945-51. PubMed ID: 9790603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gender Differences in Associations Between Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder.
    Ottosen C; Petersen L; Larsen JT; Dalsgaard S
    J Am Acad Child Adolesc Psychiatry; 2016 Mar; 55(3):227-34.e4. PubMed ID: 26903256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does ADHD predict substance-use disorders? A 10-year follow-up study of young adults with ADHD.
    Wilens TE; Martelon M; Joshi G; Bateman C; Fried R; Petty C; Biederman J
    J Am Acad Child Adolesc Psychiatry; 2011 Jun; 50(6):543-53. PubMed ID: 21621138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial risk analysis of the association between attention-deficit/hyperactivity disorder and psychoactive substance use disorder in female adolescents: a controlled study.
    Biederman J; Petty CR; Monuteaux MC; Mick E; Clarke A; Ten Haagen K; Faraone SV
    J Child Psychol Psychiatry; 2009 Mar; 50(3):352-8. PubMed ID: 19309331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does exposure to parental substance use disorders increase substance use disorder risk in offspring? A 5-year follow-up study.
    Yule AM; Wilens TE; Martelon MK; Simon A; Biederman J
    Am J Addict; 2013; 22(5):460-5. PubMed ID: 23952891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurocognitive predictors of substance use disorders and nicotine dependence in ADHD probands, their unaffected siblings, and controls: a 4-year prospective follow-up.
    Groenman AP; Oosterlaan J; Greven CU; Vuijk PJ; Rommelse N; Franke B; Hartman CA; Hoekstra PJ; Sergeant J; Faraone SV; Buitelaar J
    J Child Psychol Psychiatry; 2015 May; 56(5):521-9. PubMed ID: 25139331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alcohol, drugs, and attention-deficit/ hyperactivity disorder: a model for the study of addictions in youth.
    Wilens TE; Biederman J
    J Psychopharmacol; 2006 Jul; 20(4):580-8. PubMed ID: 16174669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Examining the nature of the association between attention-deficit hyperactivity disorder and nicotine dependence: a familial risk analysis.
    Biederman J; Pettye CR; Hammerness P; Woodworth KY; Faraon SV
    Can J Psychiatry; 2013 Mar; 58(3):177-83. PubMed ID: 23461889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Revisiting the association between attention-deficit/hyperactivity disorder and anxiety disorders: a familial risk analysis.
    Braaten EB; Beiderman J; Monuteaux MC; Mick E; Calhoun E; Cattan G; Faraone SV
    Biol Psychiatry; 2003 Jan; 53(1):93-9. PubMed ID: 12513949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ADHD, stimulant treatment in childhood and subsequent substance abuse in adulthood - a naturalistic long-term follow-up study.
    Dalsgaard S; Mortensen PB; Frydenberg M; Thomsen PH
    Addict Behav; 2014 Jan; 39(1):325-8. PubMed ID: 24090624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Family study of girls with attention deficit hyperactivity disorder.
    Faraone SV; Biederman J; Mick E; Williamson S; Wilens T; Spencer T; Weber W; Jetton J; Kraus I; Pert J; Zallen B
    Am J Psychiatry; 2000 Jul; 157(7):1077-83. PubMed ID: 10873914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A qualitative review of issues arising in the use of psycho-stimulant medications in patients with ADHD and co-morbid substance use disorders.
    Kollins SH
    Curr Med Res Opin; 2008 May; 24(5):1345-57. PubMed ID: 18384709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.